{"result": {"id": "386a3e8b-105f-4aef-95f1-119038bdc72b", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>HYPERTENSION<|>EVENT<|>Hypertension is a medical condition characterized by high blood pressure, which can lead to serious health complications if not managed properly. The text outlines treatment processes for both uncomplicated and complicated cases of hypertension, including lifestyle interventions and medication regimens.)\n##\n(\"entity\"<|>CALCIUM CHANNEL BLOCKERS<|>ORGANIZATION<|>Calcium channel blockers (CCBs) are a class of medications used to treat hypertension by relaxing blood vessels and reducing heart rate. They are denoted by 'C' in the treatment protocols mentioned in the text.)\n##\n(\"entity\"<|>DIURETICS<|>ORGANIZATION<|>Diuretics are medications that help reduce blood pressure by eliminating excess sodium and water from the body. They are denoted by 'D' in the treatment protocols mentioned in the text.)\n##\n(\"entity\"<|>ACE INHIBITORS<|>ORGANIZATION<|>ACE inhibitors are a class of drugs used to treat hypertension by relaxing blood vessels. They are denoted by 'A' in the treatment protocols mentioned in the text.)\n##\n(\"entity\"<|>BETA BLOCKERS<|>ORGANIZATION<|>Beta blockers are medications that reduce blood pressure by blocking the effects of adrenaline. They are denoted by 'B' in the treatment protocols mentioned in the text.)\n##\n(\"entity\"<|>SPC<|>ORGANIZATION<|>SPC refers to single-pill combinations, which are fixed-dose combinations of antihypertensive medications used to simplify treatment regimens. They are mentioned as part of the treatment protocols in the text.)\n##\n(\"relationship\"<|>HYPERTENSION<|>CALCIUM CHANNEL BLOCKERS<|>Calcium channel blockers are used in the treatment of hypertension as part of the medication regimen<|>7)\n##\n(\"relationship\"<|>HYPERTENSION<|>DIURETICS<|>Diuretics are used in the treatment of hypertension as part of the medication regimen<|>7)\n##\n(\"relationship\"<|>HYPERTENSION<|>ACE INHIBITORS<|>ACE inhibitors are used in the treatment of hypertension as part of the medication regimen<|>7)\n##\n(\"relationship\"<|>HYPERTENSION<|>BETA BLOCKERS<|>Beta blockers are used in the treatment of hypertension as part of the medication regimen<|>7)\n##\n(\"relationship\"<|>HYPERTENSION<|>SPC<|>Single-pill combinations are used in the treatment of hypertension to simplify medication regimens<|>6)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752166348, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 570, "prompt_tokens": 2436, "total_tokens": 3006, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 1792}, "prompt_cache_hit_tokens": 1792, "prompt_cache_miss_tokens": 644}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �量消除影响因素。主要有肥胖、代谢紊 乱 、 钠盐摄入过多等 。\n①调整降压联合方案。\n(三)高血压患者治疗流程\n　　1.无合并症高血压患者的治疗流程：无合并症 高血压患者的治疗流程见图3。\n初发高血压、经治高血压\n\n评估血压水平：\n诊室血压SBP≥140mmHg 和/或DBP≥90  mmHg,家庭 血压SBP≥135mmHg 和/或DBP≥85mmHg\n生活方式干预：以限盐及控制体重为主\n\nSBP140~160mmHg和/ 或DBP90~100 mmHg\n\n低、中危患者：\n单药治疗1个月(C、D、A、B)  不达标，联合治疗C+A 、C+D、 C+B、SPC\n注：如不达标转上级医院评估和治疗；SBP 收缩压；DBP 舒张 压 ；C 钙通道阻滞剂(二氢吡啶类);D 利尿剂；A 血管紧张素转 换酶抑制剂；或血管紧张素Ⅱ受体拮抗剂；Bβ 受体阻滞剂；SPC 单片固定复方(包括新型以及国产传统长效复方);心率快时加 β受体阻滞剂；1mmHg=0.133 kPa\n图 3 无合并症高血压患者的治疗流程\n　　2.有合并症高血压患者的治疗流程：有合并症 高血压患者的治疗流程见图4。\n　　四、基层医疗机构对高血压急症和亚急症的急 诊 处 置 [1-2】\n(一)定义\n　　高血压急症是指原发性或继发性高血压患者  在某些诱因作用下，血压突然和显著升高(一般 SBP≥180和/或DBP≥120  mmHg),同时伴有进行性 心、脑、肾等重要靶器官功能不全表现。包括高血 压脑病、高血压伴颅内出血(脑出血和蛛网膜下腔 出血)、脑梗死、心力衰竭、急性冠脉综合征(不稳定 性心绞痛、急性心肌梗死)、主动脉夹层、嗜铬细胞 瘤 危 象 、 使 用 毒 品 如 安 非 他 明 、 可 卡 因 、 迷 幻 药 等 、 围手术期高血压、子痫前期或子痫等。一部分高血 压急症并不伴有特别高的血压值，如并发急性肺水\n\n\n第一步    第二步     第三步\n\n　注 ：A血管紧张素转换酶抑制剂或血管紧张素Ⅱ受体拮抗剂；B β受体阻滞剂；C钙通道阻滞剂(二氢吡啶类);D利尿剂\n图 4   有合并症高血压患者的治疗流程\n\n肿、主动脉夹层、心肌梗死者等，而血压仅为中度升 高，但对靶器官功能影响重大，也应视为高血压急 症，治疗应使用静脉降压药物。\n　　高血压亚急症指血压\n######################\nOutput:", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_c4fc4f1d05f08c90962d6e9dd268bdb3ce591c3b676f0c92a95c78eea512e31d_v2"}